StockWatch
·
Biotechnology: Commercial Physical & Biological Resarch
InvestmentJul 1, 2026, 05:41 PM

OneMedNet Registers 11.68M Shares for Resale, Includes Yorkville SEPA

AI Summary

OneMedNet Corp. has registered up to 11,680,535 shares of common stock for resale by selling stockholders. This includes 8,500,000 shares issuable under a new Standby Equity Purchase Agreement (SEPA) with Yorkville for up to $25 million, and shares issued to directors Dr. Thomas Kosasa and Dr. Jeffrey Yu through recent private placements. The company will not receive any proceeds from the resale of these shares, which are being registered to satisfy certain registration rights.

Key Highlights

  • Registered up to 11,680,535 common shares for resale by selling stockholders.
  • Includes 8,500,000 shares issuable under a new Standby Equity Purchase Agreement (SEPA) with Yorkville.
  • SEPA allows OneMedNet to sell up to $25 million in shares to Yorkville over 36 months.
  • Dr. Thomas Kosasa invested $1.6 million for 1,885,078 shares between August 2025 and June 2026.
  • Dr. Jeffrey Yu acquired 1,295,457 shares, including $850,000 in investments and compensation conversion.
  • OneMedNet will not receive any proceeds from the resale of these registered shares.
  • Total outstanding shares as of June 30, 2026, were 56,952,652.
  • Closing stock price on June 30, 2026, was $0.711 per share.